Impact of CER Still on the Horizon, Say Health Care Stakeholders
This article was originally published in RPM Report
Executive Summary
CER remains very visible on an as-yet unattainable horizon as a source for medical treatment evidence. That’s the picture from the National Pharmaceutical Council’s fourth year of surveying health care stakeholders on comparative effectiveness research.